open access
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
open access
Abstract
Abstract
About this articleTitle
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
Journal
Issue
Pages
176-178
Published online
2021-01-11
DOI
10.5603/CJ.a2021.0002
Pubmed
Bibliographic record
Cardiol J 2021;28(1):176-178.
Authors
Francisco J. Morales-Ponce
Pablo González-Pérez
Sara Blasco-Turrión
Juan Antonio Sánchez-Brotons
Carmen Collado-Moreno
Pedro Martínez-Romero
Eduardo Martínez-Morentín
Pilar Caro-Mateo
References (4)- Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012; 307(17): 1817–1826.
- Morales-Ponce FJ, Lozano-Cid FJ, Martinez-Romero P, et al. Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction. EuroIntervention. 2019; 14(16): 1668–1675.
- Prastaro M, Pirozzi E, Gaibazzi N, et al. Expert review on the prognostic role of echocardiography after acute myocardial infarction. J Am Soc Echocardiogr. 2017; 30(5): 431–443.e2.
- McCartney PJ, Maznyczka AM, Eteiba H, et al. Low-Dose alteplase during primary percutaneous coronary intervention according to ischemic time. J Am Coll Cardiol. 2020; 75(12): 1406–1421.